Annual Operating Expenses
$127.99 M
+$36.25 M+39.51%
December 31, 2023
Summary
- As of February 7, 2025, VYGR annual total operating expenses is $127.99 million, with the most recent change of +$36.25 million (+39.51%) on December 31, 2023.
- During the last 3 years, VYGR annual operating expenses has fallen by -$15.75 million (-10.96%).
- VYGR annual operating expenses is now -17.99% below its all-time high of $156.07 million, reached on December 31, 2019.
Performance
VYGR Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$38.41 M
-$6.19 M-13.89%
September 30, 2024
Summary
- As of February 7, 2025, VYGR quarterly total operating expenses is $38.41 million, with the most recent change of -$6.19 million (-13.89%) on September 30, 2024.
- Over the past year, VYGR quarterly operating expenses has increased by +$2.41 million (+6.70%).
- VYGR quarterly operating expenses is now -17.30% below its all-time high of $46.44 million, reached on December 31, 2019.
Performance
VYGR Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
VYGR Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +39.5% | +6.7% |
| 3 y3 years | -11.0% | +66.9% |
| 5 y5 years | +29.7% | +66.9% |
VYGR Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +39.5% | -13.9% | +91.3% |
| 5 y | 5-year | -18.0% | +39.5% | -17.3% | +91.3% |
| alltime | all time | -18.0% | +790.9% | -17.3% | +950.6% |
Voyager Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $38.41 M(-13.9%) |
| Jun 2024 | - | $44.60 M(+24.9%) |
| Mar 2024 | - | $35.70 M(-0.8%) |
| Dec 2023 | $127.99 M(+39.5%) | $36.00 M(+5.5%) |
| Sep 2023 | - | $34.12 M(+12.7%) |
| Jun 2023 | - | $30.28 M(+9.7%) |
| Mar 2023 | - | $27.60 M(+19.9%) |
| Dec 2022 | $91.74 M(-17.4%) | $23.01 M(-13.6%) |
| Sep 2022 | - | $26.64 M(+32.7%) |
| Jun 2022 | - | $20.08 M(-8.8%) |
| Mar 2022 | - | $22.01 M(-1.6%) |
| Dec 2021 | $111.03 M(-22.8%) | $22.37 M(-16.0%) |
| Sep 2021 | - | $26.63 M(-11.1%) |
| Jun 2021 | - | $29.94 M(-6.7%) |
| Mar 2021 | - | $32.09 M(+6.0%) |
| Dec 2020 | $143.74 M(-7.9%) | $30.27 M(-9.2%) |
| Sep 2020 | - | $33.32 M(-11.5%) |
| Jun 2020 | - | $37.66 M(-11.4%) |
| Mar 2020 | - | $42.50 M(-8.5%) |
| Dec 2019 | $156.07 M | $46.44 M(+21.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $38.24 M(+3.6%) |
| Jun 2019 | - | $36.90 M(+7.0%) |
| Mar 2019 | - | $34.49 M(+37.0%) |
| Dec 2018 | $98.71 M(+20.4%) | $25.17 M(+8.3%) |
| Sep 2018 | - | $23.24 M(-17.8%) |
| Jun 2018 | - | $28.27 M(+28.3%) |
| Mar 2018 | - | $22.04 M(+17.9%) |
| Dec 2017 | $82.00 M(+47.7%) | $18.69 M(-23.7%) |
| Sep 2017 | - | $24.50 M(+23.7%) |
| Jun 2017 | - | $19.82 M(+4.4%) |
| Mar 2017 | - | $18.99 M(+17.2%) |
| Dec 2016 | $55.52 M(+47.7%) | $16.20 M(+18.5%) |
| Sep 2016 | - | $13.68 M(+2.6%) |
| Jun 2016 | - | $13.34 M(+8.5%) |
| Mar 2016 | - | $12.30 M(-0.6%) |
| Dec 2015 | $37.59 M(+161.6%) | $12.38 M(+38.2%) |
| Sep 2015 | - | $8.96 M(+1.2%) |
| Jun 2015 | - | $8.85 M(+19.5%) |
| Mar 2015 | - | $7.40 M(+64.7%) |
| Dec 2014 | $14.37 M | $4.50 M(+23.0%) |
| Sep 2014 | - | $3.66 M |
FAQ
- What is Voyager Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Voyager Therapeutics?
- What is Voyager Therapeutics annual operating expenses year-on-year change?
- What is Voyager Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Voyager Therapeutics?
- What is Voyager Therapeutics quarterly operating expenses year-on-year change?
What is Voyager Therapeutics annual total operating expenses?
The current annual operating expenses of VYGR is $127.99 M
What is the all time high annual operating expenses for Voyager Therapeutics?
Voyager Therapeutics all-time high annual total operating expenses is $156.07 M
What is Voyager Therapeutics annual operating expenses year-on-year change?
Over the past year, VYGR annual total operating expenses has changed by +$36.25 M (+39.51%)
What is Voyager Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of VYGR is $38.41 M
What is the all time high quarterly operating expenses for Voyager Therapeutics?
Voyager Therapeutics all-time high quarterly total operating expenses is $46.44 M
What is Voyager Therapeutics quarterly operating expenses year-on-year change?
Over the past year, VYGR quarterly total operating expenses has changed by +$2.41 M (+6.70%)